Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Oncotarget ; 9(37): 24778-24786, 2018 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-29872505

RESUMEN

P-REX2a is a PTEN inhibitor that also activates Rac 1. No associations with P-REX2a and human endometrial cancers have been reported to date. In this study, we immunohistochemically analyzed 155 uterine endometrial malignancies for P-REX2a expression. The P-REX2a-positive tumors displayed worse prognosis independent of PTEN expression. Then, we transduced either P-REX2a expression vector or short hairpin RNAs targeting P-REX2a into 2 uterine endometrioid carcinoma cell lines, OMC-2 and JHUEM-14. Ectopic expression of P-REX2a led to increased cell proliferation only in the PTEN-expressing OMC-2 cells but did not show any change in the PTEN-negative JHUEM-14 cells or the P-REX2a-knockdown cells. Induction of P-REX2a increased and knockdown of P-REX2a decreased cell migration in both cell lines. Then, we performed expression microarray analysis using these cells, and pathway analysis revealed that the expression of members of the GPCR downstream pathway displayed the most significant changes induced by the knockdown of P-REX2a. Immunohistochemical analysis revealed that Vav1, a member of the GPCR downstream pathway, was expressed in 139 of the 155 endometrial tumors, and the expression levels of Vav1 and P-REX2a showed a positive correlation (r = 0.44, p < 0.001). In conclusion, P-REX2a enhanced cell motility via the GPCR downstream pathway independently of PTEN leading to progression of uterine endometrioid malignancies and poor prognosis of the patients.

2.
Carcinogenesis ; 36(12): 1539-49, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26494227

RESUMEN

Non-alcoholic steatohepatitis (NASH) has the potential to lead to the development of cirrhosis and hepatocellular carcinoma (HCC). Connexin (Cx) 32, a hepatocyte gap-junction protein, plays a preventive role in hepatocarcinogenesis. However, the precise contribution of Cx32 in the development of NASH has not been established. In this study, we aimed to clarify the role of Cx32 and the chemopreventive effect of luteolin, an antioxidant flavonoid, on the progression of NASH and NASH-related hepatocarcinogenesis. Cx32 dominant negative transgenic (Cx32ΔTg) and wild-type (Wt) rats at 10 weeks of age were given diethylnitrosamine and fed methionine-choline-deficient diet (MCDD) or MCDD with luteolin for 12 weeks. MCDD induced steatohepatitis and fibrosis along with increased inflammatory cytokine expression and reactive oxygen species in the liver. These effects were more severe in Cx32ΔTg rats as compared with Wt rats, and significantly suppressed by luteolin in both genotypes. Concerning NASH-related hepatocarcinogenesis, the number of glutathione S-transferase placental form (GST-P)-positive foci was greater in Cx32ΔTg versus Wt rats, and significantly reduced by luteolin in Cx32ΔTg rats. Microarray analysis identified brain expressed, X-linked 1 (Bex1) as an upregulated gene in Cx32ΔTg rat liver. Quantitative RT-PCR and in situ hybridization revealed that increased Bex1 mRNA was localized in GST-P-positive foci in Cx32ΔTg rats, and the expression level was significantly decreased by luteolin. Moreover, Bex1 knockdown resulted in significant growth inhibition of the rat HCC cell lines. These results show that Cx32 and luteolin have suppressive roles in inflammation, fibrosis and hepatocarcinogenesis during NASH progression, suggesting a potential therapeutic application for NASH.


Asunto(s)
Carcinoma Hepatocelular/metabolismo , Conexinas/fisiología , Neoplasias Hepáticas Experimentales/metabolismo , Luteolina/fisiología , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Animales , Carcinoma Hepatocelular/etiología , Línea Celular Tumoral , Proliferación Celular , Conexina 26 , Conexinas/metabolismo , Citocinas/metabolismo , Progresión de la Enfermedad , Hepatocitos/fisiología , Hígado/metabolismo , Hígado/patología , Neoplasias Hepáticas Experimentales/etiología , Masculino , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Estrés Oxidativo , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología , Factores Protectores , Ratas Transgénicas , Proteína beta1 de Unión Comunicante
3.
Stem Cells ; 33(8): 2456-68, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25917344

RESUMEN

Sarcopenia, age-related muscle weakness, increases the frequency of falls and fractures in elderly people, which can trigger severe muscle injury. Rapid and successful recovery from muscle injury is essential not to cause further frailty and loss of independence. In fact, we showed insufficient muscle regeneration in aged mice. Although the number of satellite cells, muscle stem cells, decreases with age, the remaining satellite cells maintain the myogenic capacity equivalent to young mice. Transplantation of young green fluorescent protein (GFP)-Tg mice-derived satellite cells into young and aged mice revealed that age-related deterioration of the muscle environment contributes to the decline in regenerative capacity of satellite cells. Thus, extrinsic changes rather than intrinsic changes in satellite cells appear to be a major determinant of inefficient muscle regeneration with age. Comprehensive protein expression analysis identified a decrease in insulin-like growth factor-II (IGF-II) level in regenerating muscle of aged mice. We found that pro- and big-IGF-II but not mature IGF-II specifically express during muscle regeneration and the expressions are not only delayed but also decreased in absolute quantity with age. Supplementation of pro-IGF-II in aged mice ameliorated the inefficient regenerative response by promoting proliferation of satellite cells, angiogenesis, and suppressing adipogenic differentiation of platelet derived growth factor receptor (PDGFR)α(+) mesenchymal progenitors. We further revealed that pro-IGF-II but not mature IGF-II specifically inhibits the pathological adipogenesis of PDGFRα(+) cells. Together, these results uncovered a distinctive pro-IGF-II-mediated self-reinforcement mechanism of muscle regeneration and suggest that supplementation of pro-IGF-II could be one of the most effective therapeutic approaches for muscle injury in elderly people.


Asunto(s)
Envejecimiento/metabolismo , Factor II del Crecimiento Similar a la Insulina/metabolismo , Músculo Esquelético/fisiología , Precursores de Proteínas/metabolismo , Regeneración/fisiología , Células Satélite del Músculo Esquelético/metabolismo , Envejecimiento/genética , Animales , Factor II del Crecimiento Similar a la Insulina/genética , Ratones , Ratones Noqueados , Precursores de Proteínas/genética
4.
J Pharm Pharmacol ; 66(3): 418-27, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24533824

RESUMEN

OBJECTIVES: Alendronate, a nitrogen-containing bisphosphonate, is well established as a treatment for osteoporosis through regulation of osteoclast activity. Previously, the pharmacological effects of bisphosphonates on cells outside the bone environment have been considered irrelevant because of the bone-targeting property of bisphosphonates. However, the chronic effects of bisphosphonates on tissue-neighbouring bone, in particular skeletal muscles, should not be ignored because patients are treated with bisphosphonates for long periods. METHODS: Here, we show that the impact of alendronate on immortalized human myogenic cells depends on growth and differentiation-inducing conditions. KEY FINDINGS: Alendronate disrupted cytoskeletal structures and prevented migration, proliferation and differentiation of undifferentiated human myogenic cells that are involved in muscle regeneration. In contrast, alendronate did not affect the morphology, gene expression or survival of terminally differentiated human myotubes. CONCLUSIONS: The present results suggest that the muscle regeneration capacity of osteoporosis patients treated with bisphosphonates for long periods may be attenuated. The present research on the pharmacological effects of alendronate on cultured human myogenic cells will contribute to improvement of therapeutic strategies and optimization of rehabilitation programmes for locomotive activity in osteoporosis patients treated with bisphosphonates.


Asunto(s)
Alendronato/farmacología , Conservadores de la Densidad Ósea/farmacología , Diferenciación Celular , Fibras Musculares Esqueléticas/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Regeneración/efectos de los fármacos , Células Madre/efectos de los fármacos , Alendronato/efectos adversos , Conservadores de la Densidad Ósea/efectos adversos , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Humanos , Músculo Esquelético/citología , Osteoporosis/tratamiento farmacológico , Células Madre/citología
5.
Dev Genes Evol ; 222(5): 269-78, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22903233

RESUMEN

Partitioning-defective (par) genes were originally identified as genes that are essential for the asymmetric division of the Caenorhabditis elegans zygote. Studies have since revealed that the gene products are part of an evolutionarily conserved PAR-atypical protein kinase C system involved in cell polarity in various biological contexts. In this study, we analyzed the function of par6 during sea urchin morphogenesis by morpholino-mediated knockdown and by manipulation swapping of the primary mesenchyme cells (PMCs). Loss of Par6 resulted in defects in skeletogenesis and gut differentiation in larvae. Phenotypic analyses of chimeras constructed by PMC swapping showed that Par6 in non-PMCs is required for differentiation of archenteron into functional gut. In contrast, Par6 in both PMCs and ectodermal cells cooperatively regulates skeletogenesis. We suggest that Par6 in PMCs plays an immediate role in the deposition of biomineral in the syncytial cable, whereas Par6 in ectoderm may stabilize skeletal rods via an unknown signal(s).


Asunto(s)
Proteínas del Huevo/metabolismo , Erizos de Mar/crecimiento & desarrollo , Erizos de Mar/genética , Animales , Proteínas del Huevo/genética , Embrión no Mamífero/metabolismo , Tracto Gastrointestinal , Regulación del Desarrollo de la Expresión Génica , Larva/metabolismo , Mesodermo/citología , Morfogénesis , Erizos de Mar/citología , Erizos de Mar/metabolismo
6.
Exp Cell Res ; 317(2): 221-33, 2011 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-20965167

RESUMEN

A high concentration of bone morphogenetic proteins (BMPs) stimulates myogenic progenitor cells to undergo heterotopic osteogenic differentiation. However, the physiological role of the Smad signaling pathway during terminal muscle differentiation has not been resolved. We report here that Smad1/5/8 was phosphorylated and activated in undifferentiated growing mouse myogenic progenitor Ric10 cells without exposure to any exogenous BMPs. The amount of phosphorylated Smad1/5/8 was severely reduced during precocious myogenic differentiation under the high cell density culture condition even in growth medium supplemented with a high concentration of serum. Inhibition of the Smad signaling pathway by dorsomorphin, an inhibitor of Smad activation, or noggin, a specific antagonist of BMP, induced precocious terminal differentiation of myogenic progenitor cells in a cell density-dependent fashion even in growth medium. In addition, Smad1/5/8 was transiently activated in proliferating myogenic progenitor cells during muscle regeneration in rats. The present results indicate that the Smad signaling pathway is involved in a critical switch between growth and differentiation of myogenic progenitor cells both in vitro and in vivo. Furthermore, precocious cell density-dependent myogenic differentiation suggests that a community effect triggers the terminal muscle differentiation of myogenic cells by quenching the Smad signaling.


Asunto(s)
Diferenciación Celular/fisiología , Mioblastos/metabolismo , Células Satélite del Músculo Esquelético/fisiología , Transducción de Señal/fisiología , Proteínas Smad/metabolismo , Animales , Proteínas Morfogenéticas Óseas/metabolismo , Proteínas Morfogenéticas Óseas/farmacología , Proteínas Morfogenéticas Óseas/fisiología , Técnicas de Cultivo de Célula , Diferenciación Celular/efectos de los fármacos , Línea Celular , Femenino , Ratones , Ratones Endogámicos ICR , Células Musculares/citología , Células Musculares/metabolismo , Células Musculares/fisiología , Fosforilación , Ratas , Transducción de Señal/efectos de los fármacos , Proteína Smad1/metabolismo , Células Madre/citología , Células Madre/metabolismo , Células Madre/fisiología
7.
Gene Expr Patterns ; 8(5): 323-30, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18316248

RESUMEN

Partitioning-defective (Par) genes were originally identified in Caenorhabditis elegans and are involved in asymmetric divisions of the egg. Recently, the expression and function of Par orthologs have been elucidated in deuterostomes, including vertebrates. In this study, we isolated three Par-related genes, Par-1, Par-6, and atypical protein kinase C (aPKC), from the sea urchin Hemicentrotus pulcherrimus and examined their temporal and spatial expression patterns during embryogenesis up to the pluteus stage. All three transcripts existed maternally in eggs and were uniformly expressed in cleavage-stage embryos. From the blastula to early gastrula stages, HpPar-1 expression was transiently restricted to the vegetal plate, including the primary mesenchyme cells (PMCs); this transient reduction was followed by uniform expression. HpPar-6 was expressed uniformly throughout development. In contrast, HpaPKC expression changed dramatically during development. At the blastula stage, HpaPKC expression was restricted to the vegetal region, including PMCs and the vegetal plate. During gastrulation, expression was maintained in PMCs and the archenteron tip, but expression declined at the late gastrula stage. From the prism stage, two cell types started to express HpaPKC: ectoderm cells interspersed in the ciliary band and skeletogenic cells at the posterior end of the larva. At the pluteus stage, the stomach began to express HpaPKC, in addition to the interspersed ciliary band and skeletogenic cells.


Asunto(s)
Tipificación del Cuerpo , Embrión no Mamífero/metabolismo , Regulación del Desarrollo de la Expresión Génica , Erizos de Mar/genética , Animales , Erizos de Mar/embriología
8.
Dev Biol ; 314(2): 433-42, 2008 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-18166171

RESUMEN

The canonical Wnt pathway plays a central role in specifying vegetal cell fate in sea urchin embryos. SpKrl has been cloned as a direct target of nuclear beta-catenin. Using Hemicentrotus pulcherrimus embryos, here we show that HpKrl controls the specification of secondary mesenchyme cells (SMCs) through both cell-autonomous and non-autonomous means. Like SpKrl, HpKrl was activated in both micromere and macromere progenies. To examine the functions of HpKrl in each blastomere, we constructed chimeric embryos composed of blastomeres from control and morpholino-mediated HpKrl-knockdown embryos and analyzed the phenotypes of the chimeras. Micromere-swapping experiments showed that HpKrl is not involved in micromere specification, while micromere-deprivation assays indicated that macromeres require HpKrl for cell-autonomous specification. Transplantation of normal micromeres into a micromere-less host with morpholino revealed that macromeres are able to receive at least some micromere signals regardless of HpKrl function. From these observations, we propose that two distinct pathways of endomesoderm formation exist in macromeres, a Krl-dependent pathway and a Krl-independent pathway. The Krl-independent pathway may correspond to the Delta/Notch signaling pathway via GataE and Gcm. We suggest that Krl may be a downstream component of nuclear beta-catenin required by macromeres for formation of more vegetal tissues, not as a member of the Delta/Notch pathway, but as a parallel effector of the signaling (Krl-dependent pathway).


Asunto(s)
Embrión no Mamífero/fisiología , Factores de Transcripción de Tipo Kruppel/genética , Mesodermo/fisiología , Erizos de Mar/embriología , Animales , Clonación Molecular , ADN Complementario/genética , Hibridación in Situ , Larva/fisiología , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Erizos de Mar/genética , Transcripción Genética
9.
Dev Genes Evol ; 215(9): 450-59, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16078091

RESUMEN

In the sea urchin embryo, micromeres have two distinct functions: they differentiate cell autonomously into the skeletogenic mesenchyme cells and act as an organizing center that induces endomesoderm formation. We demonstrated that micro1 controls micromere specification as a transcriptional repressor. Because micro1 is a multicopy gene with at least six polymorphic loci, it has been difficult to consistently block micro1 function by morpholino-mediated knockdown. Here, to block micro1 function, we used an active activator of micro1 consisting of a fusion protein of the VP16 activation domain and the micro1 homeodomain. Embryos injected with mRNA encoding the fusion protein exhibited a phenotype similar to that of micromere-less embryos. To evaluate micro1 function in the micromere, we constructed chimeric embryos composed of animal cap mesomeres and a micromere quartet from embryos injected with the fusion protein mRNA. The chimeras developed into dauerblastulae with no vegetal structures, in which the micromere progeny constituted the blastula wall. We also analyzed the phenotype of chimeras composed of an animal cap and a mesomere expressing micro1. These chimeras developed into pluteus larvae, in which the mesomere descendants ingressed as primary mesenchyme cells and formed a complete set of skeletal rods. The hindgut and a part of the midgut were also generated from host mesomeres. However, the foregut and nonskeletogenic mesoderm were not formed in the larvae. From these observations, we conclude that micro1 is necessary and sufficient for both micromere differentiation and mid/hindgut-inducing activity, and we also suggest that micro1 may not fulfill all micromere functions.


Asunto(s)
Genes Homeobox/genética , Erizos de Mar/embriología , Erizos de Mar/genética , Animales , Blastómeros/citología , Diferenciación Celular/genética , Quimera/embriología , Quimera/genética , Embrión no Mamífero/citología , Embrión no Mamífero/metabolismo , Embrión no Mamífero/fisiología , Regulación del Desarrollo de la Expresión Génica , Genes Homeobox/fisiología , Hibridación in Situ , Mesodermo/citología , Fenotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...